Olimel N9 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N9 provides amino acid supplementation for conditions where protein metabolism is compromised.

• Premature infants: supports growth and development when endogenous amino acid production is insufficient.
• Post‑surgical patients: aids recovery by supplying essential building blocks for tissue repair.
• Chronic kidney disease patients on dialysis: helps maintain nitrogen balance and muscle mass.
• Severe malnutrition: contributes to re‑establishment of normal protein turnover.
• Metabolic disorders involving amino‑acid loss: assists in correcting deficiencies.

• Olimel N9 delivers a balanced blend of essential and non‑essential amino acids that are directly absorbed in the gastrointestinal tract. The supplied amino acids enter the systemic circulation, become substrates for protein synthesis, and support the urea cycle, gluconeogenesis, and other metabolic pathways essential for tissue growth, repair and energy production.

Adverse reactions to amino‑acid mixtures are generally mild and related to the gastrointestinal tract or hypersensitivity.

Common Side Effects

• Nausea: occasional feeling of queasiness.
• Vomiting: intermittent episodes, usually mild.
• Diarrhea: loose stools that resolve with continued use.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: transient alteration in mouthfeel.
• Injection site irritation: mild redness if administered via feeding tube.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring immediate medical attention.
• Hyperammonemia: elevated blood ammonia levels in patients with severe liver dysfunction.
• Metabolic acidosis: rare disturbance of acid‑base balance.
• Severe electrolyte imbalance: uncommon but may occur with large-volume administration.
• Hypersensitivity rash: widespread skin eruption.
• Pulmonary edema: extremely rare fluid accumulation in lungs.

When using Olimel N9, consider patient‑specific factors and follow standard handling practices.

• Renal impairment: adjust volume based on individual fluid tolerance.
• Hepatic dysfunction: monitor ammonia levels during therapy.
• Electrolyte monitoring: check serum electrolytes regularly in high‑risk patients.
• Feeding tube compatibility: verify that the formulation does not clog the tube.
• Pediatric use: dose must be calculated by a qualified clinician.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Amino‑acid mixtures can interact with certain medications and clinical conditions.

Major Interactions (Avoid)

• Phenylalanine‑containing formulations: may exacerbate phenylketonuria.
• High‑protein enteral formulas: risk of excessive nitrogen load.

Moderate Interactions (Monitor Closely)

• Anticonvulsants (e.g., valproate): may alter plasma amino‑acid levels.
• Diuretics: increase risk of electrolyte disturbances when combined with large‑volume amino‑acid solutions.
• Insulin therapy: may require adjustment of carbohydrate content in the nutrition regimen.
• Renal replacement therapies: affect clearance of administered amino acids.
• Thyroid hormone replacement: monitor thyroid function tests as amino‑acid load can influence hormone binding.